Dishman teams with Codexis’ for cost saving enzymatic API tech
Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.
Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.
Helvoet Pharma is to build a €14m ($19m) rubber parenteral packaging component facility in India to meet rising demand for products made to international quality standards.
US Pharma firms can benefit from the sourcing, storage and distribution efficiencies offered by comparator drug sourcing and distribution specialist Pharmarama says managing director Rosemary Bensley.
Eli Lilly, Merck & Co and Pfizer are combining resources to form the Asian Cancer Research Group (ACRG), a non-profit company which aims to accelerate research into lung and gastric cancers in Asia.
Aesica is looking to acquire manufacturing assets in the US to expand its client base in the country and continue the growth it has maintained throughout the economic downturn.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Noven, Inspire, AP Pharma and Tarsa Therapeutics.